{"transactions":[{"id":4627799,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-28T21:15:08.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":54750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on September 24, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":54750,"derivative":{"exercise_price":3.39,"expiration_date":"2036-09-23","underlying":"Common Stock","underlying_shares":54750},"source":{"system":"sec-edgar","filing":"0002024096-26-000015","document":"form4-09282026_050904.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000015/form4-09282026_050904.xml","form_type":"4"}},{"id":4627798,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-09-28T21:15:08.000Z","date":"2026-09-14","kind":"grant","planned":false,"acquired":true,"shares":2110,"price":2.644,"value":5578.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 97,026 Restricted Stock Units."}],"balance_after":138288,"source":{"system":"sec-edgar","filing":"0002024096-26-000015","document":"form4-09282026_050904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000015/form4-09282026_050904.xml","form_type":"4"}},{"id":681738,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-08-19T21:00:08.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":1304,"price":4.9571,"value":6464.0584,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.94 to $5.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 97,026 Restricted Stock Units."}],"balance_after":136178,"source":{"system":"sec-edgar","filing":"0002024096-26-000013","document":"form4-08192026_050801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000013/form4-08192026_050801.xml","form_type":"4"}},{"id":721572,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:49:07.000Z","date":"2026-07-01","kind":"sale","planned":false,"acquired":false,"shares":4666,"price":4.48,"value":20903.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of performance Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $4.35 to $4.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 100,621 RSUs.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":137482,"source":{"system":"sec-edgar","filing":"0002024096-26-000011","document":"form4-07012026_100702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000011/form4-07012026_100702.xml","form_type":"4"}},{"id":721571,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-07-01T22:49:07.000Z","date":"2026-06-29","kind":"grant","planned":false,"acquired":true,"shares":12060,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":142148,"source":{"system":"sec-edgar","filing":"0002024096-26-000011","document":"form4-07012026_100702.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000011/form4-07012026_100702.xml","form_type":"4"}},{"id":770258,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-05-20T20:30:17.000Z","date":"2026-05-18","kind":"sale","planned":false,"acquired":false,"shares":1302,"price":5.074,"value":6606.348,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $5.06 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 100,621 Restricted Stock Units."}],"balance_after":130088,"source":{"system":"sec-edgar","filing":"0002024096-26-000009","document":"form4-05202026_040507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000009/form4-05202026_040507.xml","form_type":"4"}},{"id":838635,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-03-18T01:14:36.000Z","date":"2026-03-13","kind":"grant","planned":false,"acquired":true,"shares":5930,"price":2.644,"value":15678.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 104,216 restricted stock units."}],"balance_after":131390,"source":{"system":"sec-edgar","filing":"0002024096-26-000007","document":"form4-03182026_010330.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000007/form4-03182026_010330.xml","form_type":"4"}},{"id":891005,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T22:05:09.000Z","date":"2026-02-18","kind":"sale","planned":false,"acquired":false,"shares":3016,"price":6.3972,"value":19293.9552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $6.22 to $6.47. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 104,216 Restricted Stock Units."}],"balance_after":125460,"source":{"system":"sec-edgar","filing":"0002024096-26-000005","document":"form4-02202026_050205.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000005/form4-02202026_050205.xml","form_type":"4"}},{"id":891004,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-20T22:05:04.000Z","date":"2025-11-18","kind":"sale","planned":false,"acquired":false,"shares":721,"price":9.27,"value":6683.67,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On November 20, 2025, the reporting person filed a Form 4 which inadvertently reported that a sale to cover tax obligations occurred on August 18, 2025. In fact, as reported in this amendment, the sale occurred on November 18, 2025."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 47,733 RSUs."}],"balance_after":63476,"source":{"system":"sec-edgar","filing":"0002024096-26-000004","document":"form4a-02202026_050201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000004/form4a-02202026_050201.xml","form_type":"4/A","original_submission_date":"2025-11-20"}},{"id":916221,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-06T22:00:10.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":260000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on February 4, 2027, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":260000,"derivative":{"exercise_price":7.27,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":260000},"source":{"system":"sec-edgar","filing":"0002024096-26-000002","document":"form4-02062026_050203.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000002/form4-02062026_050203.xml","form_type":"4"}},{"id":916220,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:00:10.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2027, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 112,733 RSUs."}],"balance_after":128476,"source":{"system":"sec-edgar","filing":"0002024096-26-000002","document":"form4-02062026_050203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409626000002/form4-02062026_050203.xml","form_type":"4"}},{"id":992728,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-11-20T22:14:54.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":721,"price":9.27,"value":6683.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 47,733 RSUs."}],"balance_after":63476,"source":{"system":"sec-edgar","filing":"0002024096-25-000005","document":"form4-11202025_101149.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409625000005/form4-11202025_101149.xml","form_type":"4"}},{"id":1016994,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:28:16.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":24,"price":9.561,"value":229.464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $9.53 to $9.59. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 49,687 RSUs.  Each RSU represents a contingent right to receive one share of Common Stock of the Issuer."}],"balance_after":64197,"source":{"system":"sec-edgar","filing":"0002024096-25-000003","document":"form4-10172025_111011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409625000003/form4-10172025_111011.xml","form_type":"4"}},{"id":1016993,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:28:16.000Z","date":"2025-10-17","kind":"sale","planned":false,"acquired":false,"shares":2091,"price":8.935,"value":18683.085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $8.53 to $9.52. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price."}],"balance_after":64221,"source":{"system":"sec-edgar","filing":"0002024096-25-000003","document":"form4-10172025_111011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409625000003/form4-10172025_111011.xml","form_type":"4"}},{"id":1016992,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-10-17T23:28:16.000Z","date":"2025-10-15","kind":"grant","planned":false,"acquired":true,"shares":5940,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":66312,"source":{"system":"sec-edgar","filing":"0002024096-25-000003","document":"form4-10172025_111011.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000202409625000003/form4-10172025_111011.xml","form_type":"4"}},{"id":1060480,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-08-20T21:05:06.000Z","date":"2025-08-18","kind":"sale","planned":false,"acquired":false,"shares":2848,"price":4.668,"value":13294.464,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a sale to cover tax obligations on the release of restricted stock units (\"RSUs\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 49,687 RSUs."}],"balance_after":60372,"source":{"system":"sec-edgar","filing":"0001415889-25-022479","document":"form4-08202025_090801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000141588925022479/form4-08202025_090801.xml","form_type":"4"}},{"id":1174849,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-04-09T21:48:02.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":5720,"price":2.61,"value":14929.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Lexeo Therapeutics, Inc. 2023 Employee Stock Purchase Plan. This transaction is exempt under both Rule 16b-3(c) and Rule 16b-3(d)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 57,500 restricted stock units."}],"balance_after":63220,"source":{"system":"sec-edgar","filing":"0001415889-25-010505","document":"form4-04092025_090458.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000141588925010505/form4-04092025_090458.xml","form_type":"4"}},{"id":1305504,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-10T21:55:13.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares underlying the option vest and become exercisable on January 7, 2026, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":52500,"derivative":{"exercise_price":7.33,"expiration_date":"2035-01-06","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001415889-25-001286","document":"form4-01102025_040108.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000141588925001286/form4-01102025_040108.xml","form_type":"4"}},{"id":1305503,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-01-10T21:55:13.000Z","date":"2025-01-07","kind":"grant","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on February 15, 2026, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reported securities are RSUs."}],"balance_after":57500,"source":{"system":"sec-edgar","filing":"0001415889-25-001286","document":"form4-01102025_040108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000141588925001286/form4-01102025_040108.xml","form_type":"4"}},{"id":1479459,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T13:04:46.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":187500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying the option shall vest on May 20, 2025, and 1/48th of the shares underlying the option shall vest in monthly installments thereafter, subject to the Reporting Person's continuous service."}],"balance_after":187500,"derivative":{"exercise_price":18.19,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":187500},"source":{"system":"sec-edgar","filing":"0000950170-24-073371","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000095017024073371/ownership.xml","form_type":"4"}},{"id":1479458,"issuer":{"id":5687,"kind":"organization","name":"Lexeo Therapeutics, Inc.","symbol":"LXEO"},"owners":[{"id":21723,"kind":"person","name":"Otero Jose Manuel","position":1,"cik":"0002024096","reported_name":"Otero Jose Manuel","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Technical Officer"}}],"security":"Common Stock","published_at":"2024-06-14T13:04:46.000Z","date":"2024-06-12","kind":"grant","planned":true,"acquired":true,"shares":31250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities are restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. Twenty-five percent (25%) of the RSUs shall vest on August 15, 2025, and 1/16th of the RSUs shall vest in quarterly installments thereafter on the Issuer's standard quarterly vesting dates, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0000950170-24-073371","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2024096/000095017024073371/ownership.xml","form_type":"4"}}]}